fluconazole has been researched along with Opportunistic Infections in 178 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Opportunistic Infections: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Cefpirome was administered as prophylaxis against bacterial infection, and meropenem+minocycline as an empiric window therapy for febrile neutropenia." | 9.14 | [Comparison of micafungin and fosfluconazole as prophylaxis for invasive fungal infection during neutropenia in children undergoing chemotherapy and hematopoietic stem cell transplantation]. ( Higuchi, B; Hirano, S; Inoue, M; Ishihara, T; Kawa, K; Kondo, O; Kouroki, M; Koyama, M; Sakata, A; Sakata, N; Sawada, A; Takeshita, Y; Yasui, M; Yoshioka, A, 2009) |
| "In an international, randomized, double-blind trial, we compared oral posaconazole with oral fluconazole for prophylaxis against invasive fungal infections in patients with graft-versus-host disease (GVHD) who were receiving immunosuppressive therapy." | 9.12 | Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. ( Boparai, N; Chandrasekar, P; Durrant, S; Greinix, H; Langston, A; Lipton, JH; Morais de Azevedo, W; Patino, H; Pedicone, L; Reddy, V; Tarantolo, SR; Ullmann, AJ; Vesole, DH, 2007) |
| "In this randomized, multicenter study involving evaluators who were unaware of treatment assignments, we compared the efficacy and safety of posaconazole with those of fluconazole or itraconazole as prophylaxis for patients with prolonged neutropenia." | 9.12 | Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. ( Angulo-Gonzalez, D; Cornely, OA; Goh, YT; Hardalo, C; Helfgott, D; Holowiecki, J; Maertens, J; Perfect, J; Petrini, M; Stockelberg, D; Suresh, R; Ullmann, AJ; Walsh, TJ; Winston, DJ, 2007) |
| " The aim of the present study was to evaluate the safety and efficacy of oral fluconazole for empirical antifungal therapy in neutropenic patients with persistent fever." | 9.11 | Oral fluconazole for empiric treatment of prolonged Fever in neutropenic patients: prospective study in 250 consecutive patients after stem cell transplantation. ( Hardan, I; Maor, Y; Stemmer, SM, 2004) |
| "Thirty-four patients with collagen diseases suffering from onychomycosis were treated with fluconazole and showed remarkable improvement." | 9.08 | [Effects of fluconazole on onychomycosis in the patients with collagen diseases]. ( Iwamoto, I; Izumi, H; Nawata, Y; Otawa, M; Sueishi, M; Sugiyama, T; Sumida, T; Takabayashi, K; Tanabe, E; Tomioka, H, 1995) |
| "Amphotericin B, despite its intrinsic servere toxicity, is the most commonly used empirical antifungal therapy in cancer patients with unexplained fever not responding to empirical antibacterial therapy." | 9.08 | Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial. ( Caselli, D; Castagnola, E; Congiu, M; Fanci, R; Garaventa, A; Giacchino, M; Menichetti, F; Moroni, C; Rossi, MR; Van Lint, MT; Viscoli, C, 1996) |
| "Prophylactic fluconazole prevents colonization and superficial infections by Candida species other than Candida krusei in patients undergoing chemotherapy for acute leukemia and is well tolerated." | 9.07 | Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. ( Buell, DN; Chandrasekar, PH; Goodman, JL; Ho, WG; Horowitz, H; Islam, MZ; Lazarus, HM; Rosenfeld, CS; Shadduck, RK; Silber, JL; Winston, DJ, 1993) |
| "The efficacy and safety of fluconazole in the treatment of oesophageal candidiasis in patients with the acquired immunodeficiency syndrome (AIDS) was assessed in 36 patients." | 9.07 | Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS. ( Dupla, ML; García-Puig, J; Gil, A; Khamashta, MA; Lavilla, P; Ortiz-Vázquez, J; Pintado, V; Valencia, E, 1991) |
| "Amphotericin B used in combination with flucytosine has superior mycologic and clinical efficacy compared with fluconazole for the treatment of cryptococcal meningitis in patients with AIDS." | 9.06 | Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. ( Chan, LS; Larsen, RA; Leal, MA, 1990) |
| "To compare the benefits and harms of voriconazole with those of amphotericin B and fluconazole when used for prevention or treatment of invasive fungal infections in cancer patients with neutropenia." | 8.90 | Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia. ( Dalbøge, CS; Gøtzsche, PC; Johansen, HK; Jørgensen, KJ, 2014) |
| "To compare the benefits and harms of voriconazole with those of amphotericin B and fluconazole when used for prevention or treatment of invasive fungal infections in cancer patients with neutropenia." | 8.83 | Voriconazole versus amphotericin B in cancer patients with neutropenia. ( Gøtzsche, PC; Johansen, HK; Jørgensen, KJ, 2006) |
| "Fluconazole is a novel triazole antifungal drug chiefly used in the treatment of opportunistic mycoses in immuno-compromised patients, particularly those with the acquired immuno-deficiency syndrome (AIDS)." | 8.78 | Fluconazole. Review and situation among antifungal drugs in the treatment of opportunistic mycoses of human immuno-deficiency virus infections. ( Lafaix, C; Patey, ON; Vincent-Ballereau, FN, 1991) |
| "Fungal infections are a major cause of morbidity and mortality in patients undergoing induction chemotherapy for acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS)." | 6.71 | Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome. ( Beran, M; Cortes, J; Estey, E; Giles, F; Kantarjian, H; Koller, C; Kontoyiannis, D; Mattiuzzi, GN; Munsell, M; Raad, I; Shen, Y, 2003) |
| "Cryptococcal meningitis associated with acquired immunodeficiency syndrome (AIDS) is particularly common in tropical Africa." | 5.28 | Cryptococcal meningitis associated with acquired immunodeficiency syndrome (AIDS) in African patients: treatment with fluconazole. ( Aubry, P; Bogaerts, J; Dupont, B; Durbec, JP; Kadio, A; Laroche, R; Latif, A; M'Pele, P; Taelman, H; Touze, JE, 1992) |
| "Fluconazole was 5-20-fold more active than ketoconazole against systemic aspergillosis and against systemic, intracranial and pulmonary cryptococcosis but was less active than amphotericin B." | 5.27 | Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. ( Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF, 1987) |
| " Cefpirome was administered as prophylaxis against bacterial infection, and meropenem+minocycline as an empiric window therapy for febrile neutropenia." | 5.14 | [Comparison of micafungin and fosfluconazole as prophylaxis for invasive fungal infection during neutropenia in children undergoing chemotherapy and hematopoietic stem cell transplantation]. ( Higuchi, B; Hirano, S; Inoue, M; Ishihara, T; Kawa, K; Kondo, O; Kouroki, M; Koyama, M; Sakata, A; Sakata, N; Sawada, A; Takeshita, Y; Yasui, M; Yoshioka, A, 2009) |
| "In an international, randomized, double-blind trial, we compared oral posaconazole with oral fluconazole for prophylaxis against invasive fungal infections in patients with graft-versus-host disease (GVHD) who were receiving immunosuppressive therapy." | 5.12 | Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. ( Boparai, N; Chandrasekar, P; Durrant, S; Greinix, H; Langston, A; Lipton, JH; Morais de Azevedo, W; Patino, H; Pedicone, L; Reddy, V; Tarantolo, SR; Ullmann, AJ; Vesole, DH, 2007) |
| "In this randomized, multicenter study involving evaluators who were unaware of treatment assignments, we compared the efficacy and safety of posaconazole with those of fluconazole or itraconazole as prophylaxis for patients with prolonged neutropenia." | 5.12 | Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. ( Angulo-Gonzalez, D; Cornely, OA; Goh, YT; Hardalo, C; Helfgott, D; Holowiecki, J; Maertens, J; Perfect, J; Petrini, M; Stockelberg, D; Suresh, R; Ullmann, AJ; Walsh, TJ; Winston, DJ, 2007) |
| " The aim of the present study was to evaluate the safety and efficacy of oral fluconazole for empirical antifungal therapy in neutropenic patients with persistent fever." | 5.11 | Oral fluconazole for empiric treatment of prolonged Fever in neutropenic patients: prospective study in 250 consecutive patients after stem cell transplantation. ( Hardan, I; Maor, Y; Stemmer, SM, 2004) |
| "Thirty-four patients with collagen diseases suffering from onychomycosis were treated with fluconazole and showed remarkable improvement." | 5.08 | [Effects of fluconazole on onychomycosis in the patients with collagen diseases]. ( Iwamoto, I; Izumi, H; Nawata, Y; Otawa, M; Sueishi, M; Sugiyama, T; Sumida, T; Takabayashi, K; Tanabe, E; Tomioka, H, 1995) |
| "Amphotericin B, despite its intrinsic servere toxicity, is the most commonly used empirical antifungal therapy in cancer patients with unexplained fever not responding to empirical antibacterial therapy." | 5.08 | Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial. ( Caselli, D; Castagnola, E; Congiu, M; Fanci, R; Garaventa, A; Giacchino, M; Menichetti, F; Moroni, C; Rossi, MR; Van Lint, MT; Viscoli, C, 1996) |
| "The efficacy and safety of fluconazole in the treatment of oesophageal candidiasis in patients with the acquired immunodeficiency syndrome (AIDS) was assessed in 36 patients." | 5.07 | Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS. ( Dupla, ML; García-Puig, J; Gil, A; Khamashta, MA; Lavilla, P; Ortiz-Vázquez, J; Pintado, V; Valencia, E, 1991) |
| "Prophylactic fluconazole prevents colonization and superficial infections by Candida species other than Candida krusei in patients undergoing chemotherapy for acute leukemia and is well tolerated." | 5.07 | Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. ( Buell, DN; Chandrasekar, PH; Goodman, JL; Ho, WG; Horowitz, H; Islam, MZ; Lazarus, HM; Rosenfeld, CS; Shadduck, RK; Silber, JL; Winston, DJ, 1993) |
| "The recently developed antifungal agents itraconazole and fluconazole have been evaluated for primary and maintenance therapy for mycoses in patients with acquired immune deficiency syndrome (AIDS) in comparative and non-comparative trials." | 5.07 | Opportunistic fungal infections in patients with acquired immune deficiency syndrome. ( Viviani, MA, 1992) |
| "Amphotericin B used in combination with flucytosine has superior mycologic and clinical efficacy compared with fluconazole for the treatment of cryptococcal meningitis in patients with AIDS." | 5.06 | Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. ( Chan, LS; Larsen, RA; Leal, MA, 1990) |
| "To compare the benefits and harms of voriconazole with those of amphotericin B and fluconazole when used for prevention or treatment of invasive fungal infections in cancer patients with neutropenia." | 4.90 | Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia. ( Dalbøge, CS; Gøtzsche, PC; Johansen, HK; Jørgensen, KJ, 2014) |
| "To compare the benefits and harms of voriconazole with those of amphotericin B and fluconazole when used for prevention or treatment of invasive fungal infections in cancer patients with neutropenia." | 4.83 | Voriconazole versus amphotericin B in cancer patients with neutropenia. ( Gøtzsche, PC; Johansen, HK; Jørgensen, KJ, 2006) |
| " Fluconazole (Diflucan) is currently the standard prophylactic agent for candidiasis, although mold-active agents and alternative strategies for polyene administration are being investigated." | 4.81 | Antifungal prophylaxis in hematopoietic stem cell transplant recipients. ( Marr, KA, 2001) |
| "The addition of itraconazole and fluconazole to the antifungal armamentarium has resulted in less toxic, easily administered therapy for both endemic and opportunistic mycoses." | 4.79 | Role of azoles in antifungal therapy. ( Kauffman, CA, 1996) |
| "A case of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) associated with pulmonary cryptococcosis which was successfully treated with fluconazole (FCZ) and flucytosine (5-FC) is described." | 4.78 | [A case report--pulmonary cryptococcosis associated with systemic lupus erythematosus and review of 44 cases in Japan]. ( Kano, S; Minato, N; Saito, K; Saito, T; Saku, N; Sato, M; Suzuki, N; Takeda, A, 1993) |
| "Fluconazole is a novel triazole antifungal drug chiefly used in the treatment of opportunistic mycoses in immuno-compromised patients, particularly those with the acquired immuno-deficiency syndrome (AIDS)." | 4.78 | Fluconazole. Review and situation among antifungal drugs in the treatment of opportunistic mycoses of human immuno-deficiency virus infections. ( Lafaix, C; Patey, ON; Vincent-Ballereau, FN, 1991) |
| " Patients bearing the Y238X polymorphism in the DECTIN-1 gene were more likely to be colonized with Candida species, compared with patients bearing wild-type DECTIN-1, necessitating more frequent use of fluconazole in the prevention of systemic Candida infection." | 3.75 | Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. ( Adema, G; Blijlevens, NM; Brown, GD; Donnelly, JP; Ferwerda, B; Feuth, T; Kullberg, BJ; Netea, MG; Plantinga, TS; van der Velden, WJ; van Spriel, AB, 2009) |
| "A 22-yr-old male with acute lymphoblastic leukemia and Candida krusei fungemia failed therapy with fluconazole and amphotericin B." | 3.72 | Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent. ( McGee, WT; Tereso, GJ, 2003) |
| " We describe the unanticipated problems we encountered in collecting data for a meta-analysis comparing a new antifungal agent, fluconazole, with amphotericin B in patients with cancer complicated by neutropenia." | 3.70 | Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis. ( Gotzsche, PC; Johansen, HK, 1999) |
| "Fungal infections are a major cause of morbidity and mortality in patients undergoing induction chemotherapy for acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS)." | 2.71 | Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome. ( Beran, M; Cortes, J; Estey, E; Giles, F; Kantarjian, H; Koller, C; Kontoyiannis, D; Mattiuzzi, GN; Munsell, M; Raad, I; Shen, Y, 2003) |
| " Itraconazole has a broader spectrum of activity but the capsules give erratic bioavailability in neutropenic patients." | 2.69 | A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group. ( Morgenstern, GR; Prentice, AG; Prentice, HG; Ropner, JE; Schey, SA; Warnock, DW, 1999) |
| "In neutropenic patients with hematologic malignancies, prophylaxis with fluconazole significantly decreased fungal isolation and other indicators of fungal infection when compared with amphotericin B." | 2.69 | Fluconazole versus amphotericin B for the prevention of fungal infection in neutropenic patients with hematologic malignancy. ( Fujimori, Y; Kakishita, E; Kanamaru, A; Okada, M; Okamoto, T; Takatsuka, H; Takemoto, Y; Tamura, S; Wada, H, 1999) |
| " Adverse events, plasma levels, and clinical response were examined." | 2.68 | Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections. ( Anaissie, EJ; Bodey, GP; Bosso, J; Huls, C; Karl, C; Kontoyiannis, DP; Prince, RA; Vartivarian, SE, 1995) |
| " Prophylactic fluconazole was safe and significantly reduced systemic fungal infections with other benefits, including improved survival at day 110 after marrow transplantation." | 2.68 | Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. ( Adams, R; Bowden, RA; Feldman, AR; Levenstein, MJ; Meyers, JD; Osborne, B; Schoch, HG; Slavin, MA, 1995) |
| "The epidemiology of invasive fungal infections (IFIs) in immunocompromised individuals has changed over the last few decades, partially due to the increased use of antifungal agents to prevent IFIs." | 2.66 | Breakthrough invasive fungal infections: Who is at risk? ( Chen, SC; Cornely, OA; Hoenigl, M; Jenks, JD; Thompson, GR, 2020) |
| "Amphotericin B was started thereafter but discontinued three days later in favor of fluconazole 400 mg/d due to worsening renal function." | 2.61 | Clinical diversity of invasive cryptococcosis in AIDS patients from central China: report of two cases with review of literature. ( Cao, Q; Cooper, B; Gui, X; Sherer, R; Zhang, Y, 2019) |
| "Micafungin was marginally more effective than fluconazole for the prevention of all mold infections (OR = 0." | 2.50 | Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis. ( Kourbeti, IS; Mylonakis, E; Ziakas, PD, 2014) |
| "Cryptococcosis is an important opportunistic fungal infection, especially in the immunocompromised patient." | 2.45 | Cryptococcal lung disease. ( Baddley, JW; Shirley, RM, 2009) |
| "We present another case of infectious spondylodiscitis due to B." | 2.45 | Spondylodiscitis due to an emergent fungal pathogen: Blastoschizomyces capitatus, a case report and review of the literature. ( Celik, AD; Kantarcioglu, S; Mert, A; Ozaras, R; Ozturk, R; Tabak, F, 2009) |
| "Balamuthia mandrillaris meningoencephalitis is a rare but often fatal infection; only 2 survivors have been reported to date worldwide." | 2.42 | Balamuthia mandrillaris meningoencephalitis in an immunocompetent patient: an unusual clinical course and a favorable outcome. ( Chang, HT; Jung, S; Schelper, RL; Visvesvara, GS, 2004) |
| " However, bioavailability of itraconazole is reduced in patients with raised gastric pH and no i." | 2.39 | [Prophylaxis against mycoses in neutropenic patients]. ( Arning, M; Aul, C, 1994) |
| "Fluconazole has been shown effective as prophylaxis of candidosis including in patients undergoing bone marrow transplantation as well as in treatment of oropharyngeal candidosis and for candidaemia occurring in non-neutropenic patients." | 2.39 | [Therapy of systemic candidiasis]. ( Meunier, F, 1994) |
| "The authors report a case of AIDS revealed by pleuropulmonary cryptococcosis." | 2.38 | [Pleuropulmonary cryptococcosis disclosing AIDS]. ( Akoun, G; Denis, M; Lechapt, E; Mayaud, C; Milleron, B; Zalcman, G, 1991) |
| "I have tried to use the AIDS commentaries to keep up with these advances." | 2.38 | Azoles and AIDS. ( Larsen, RA, 1990) |
| "A 56-year-old Japanese man with ulcerative colitis and a history of Sweet's syndrome who was taking prednisolone and azathioprine presented with a moderate exacerbation of ulcerative colitis, abdominal pain, diarrhea, and bloody stools along with cytomegalovirus infection." | 1.91 | Ulcerative colitis successfully treated with vedolizumab in the presence of comorbid opportunistic infections: a case report. ( Ichimori, T; Ishikawa, Y; Nagano, S; Oki, Y; Uchida, K; Yamada, T, 2023) |
| "Here, we reported a case living with chronic hepatitis B virus infection who had a recurrent pulmonary cryptococcosis." | 1.62 | Recurrent pulmonary cryptococcosis during chronic HBV infection: A case report. ( Liu, H; Shen, S; Wang, Q, 2021) |
| "Cryptococcal meningitis is an opportunistic infection predominantly affecting immunocompromised patients but rarely can affect the immunocompetent." | 1.51 | Rare presentation of cryptococcal meningitis in an immunocompetent patient. ( Khattab, A; Patruni, S; Sealey, ML, 2019) |
| "Cryptococcosis is an important opportunistic infection of organ transplant recipients." | 1.48 | Cryptococcoma of a transplanted kidney in a patient presenting with recurrent urinary tract infection: a case report. ( Greeff, L; Karusseit, VOL; Lengano, T; Muranda, AZ; Sathekge, MM, 2018) |
| "Adult T-cell leukemia/lymphoma (ATLL) is usually preceded by infection with human T-cell lymphotropic virus I (HTLV-I)." | 1.43 | A Case of Pneumonia Caused by Pneumocystis Jirovecii and Cryptococcus Neoformans in a Patient with HTLV-1 Associated Adult T- Cell Leukemia/Lymphoma: Occam's Razor Blunted. ( Cunha, BA; Desai, A; Fe, A; Ilowite, J; Mathew, JP, 2016) |
| "The patient with cryptococcal meningitis was treated with amphotericin B and fluconazole and the patient with cerebral aspergilloma with voriconazole." | 1.38 | Two rare cases of central nervous system opportunistic mycoses. ( Baršić, B; Mlinarić Missoni, E, 2012) |
| "glabrata fungemia were systematically recorded." | 1.36 | Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients. ( Adrie, C; Clec'h, C; Cohen, Y; Gauzit, R; Karoubi, P; Marsepoil, T; Zarka, D, 2010) |
| "Isavuconazole (BAL4815) is a promising novel broad-spectrum triazole in late-stage clinical development that has proven active in vitro against Aspergillus and Candida species." | 1.35 | In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species. ( Bouza, E; Guinea, J; Peláez, T; Recio, S; Torres-Narbona, M, 2008) |
| "Cryptococcosis is the third most common invasive fungal infection in organ transplant recipients after candidiasis and aspergillosis." | 1.33 | Intracranial granuloma and skull osteolysis: complication of a primary cutaneous cryptococcosis in a kidney transplant recipient. ( Aldigier, JC; Diaconita, M; Le Meur, Y; Paraf, F; Rerolle, JP; Szelag, JC, 2005) |
| "Invasive fungal infections are fatal complications for patients on chemotherapy, and antifungal prophylactic treatment has been commonly recommended." | 1.33 | Cost-effectiveness analysis of antifungal treatment for patients on chemotherapy. ( Kawasugi, K; Morimoto, T; Nomura, K, 2006) |
| "Fluconazole prophylaxis was not used during the study period." | 1.32 | Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis. ( Anttila, VJ; Jantunen, E; Juvonen, E; Nihtinen, A; Parkkali, T; Ruutu, T; Volin, L, 2004) |
| "This study of patients with advanced cancer has demonstrated a high incidence of oral colonization with non-C." | 1.32 | High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer. ( Al, MA; Bagg, J; Baxter, W; Coleman, D; Jackson, MS; Lewis, MA; McEndrick, S; McHugh, S; Sweeney, MP, 2003) |
| "neoformans in the brains and lungs of MAIDS mice, the pathogen grew in the brains of MAIDS mice treated with fluconazole." | 1.31 | Lanoconazole, a new imidazole antimycotic compound, protects MAIDS mice against encephalitis caused by Cryptococcus neoformans. ( Furukawa, K; Pollard, RB; Sasaki, H; Suzuki, F, 2000) |
| "Fluconazole MICs were 16 (3 SDD strains) and 128 microg/ml (1 resistant strain), respectively." | 1.31 | Frequency and clinical significance of bloodstream infections caused by C albicans strains with reduced susceptibility to fluconazole. ( Alcalá, L; Bouza, E; Fernández-Turégano, CP; Muñoz, P; Peláez, T; Rodríguez-Créixems, M, 2002) |
| "A 19-year-old female with aplastic anemia who developed subglottal aspergillosis is reported." | 1.31 | Invasive subglottal aspergillosis in a patient with severe aplastic anemia: a case report. ( Itoh, S; Kajiwara, M; Kumagai, J; Nagasawa, M; Sugimoto, T; Tomizawa, D, 2002) |
| "Fluconazole seems to be an effective and well-tolerated agent in the treatment of severe life-threatening systemic candidiasis, and a very good alternative to amphotericin B, in cardiac surgery patients." | 1.30 | Systemic candidiasis in cardiac surgery patients. ( Geroulanos, S; Kriaras, J; Michalopoulos, A, 1997) |
| "Fluconazole is an antifungal agent commonly used in liver transplant patients." | 1.30 | Addisonian crisis in a liver transplant patient due to fluconazole withdrawal. ( Cohen, RM; Hanto, DW; Martin, J; Tiao, GM; Weber, FL, 1999) |
| "No fungal infections were observed during this period, and all patients provided negative cultures." | 1.30 | Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group. ( Borro, JM; Calvo, V; Morales, P; Morcillo, A; París, F; Tarrazona, V; Vicente, R, 1999) |
| "Treatment with fluconazole was effective in 2 months on the cryptococcosis." | 1.29 | [Cutaneous and lymphatic cryptococcosis after transient lymphopenia in an immunocompetent patient]. ( Aubin, F; Barale, T; Gil, H; Humbert, P; Reboux, G, 1995) |
| "Thirty adults (15 with ARC and 15 with AIDS) with a first episode of thrush candidiasis were given oral fluconazole (Triflucan 50 mg; one capsule daily) for at least three months." | 1.28 | [Treatment and secondary prophylaxis with fluconazole for oropharyngeal candidiasis in HIV-positive patients. A mycological analysis of failures]. ( André, D; Bastide, JM; Janbon, F; Mallié, M; Reynes, J, 1992) |
| "Cryptococcal meningitis associated with acquired immunodeficiency syndrome (AIDS) is particularly common in tropical Africa." | 1.28 | Cryptococcal meningitis associated with acquired immunodeficiency syndrome (AIDS) in African patients: treatment with fluconazole. ( Aubry, P; Bogaerts, J; Dupont, B; Durbec, JP; Kadio, A; Laroche, R; Latif, A; M'Pele, P; Taelman, H; Touze, JE, 1992) |
| "Fluconazole has shown effectiveness in maintenance therapy, being not be possible to evaluate it as an acute phase therapy because the low number of cases in which it was studied." | 1.28 | [Cryptococcosis in AIDS patients: a study of 19 cases]. ( Adrados de Llano, M; García Aguado, C; Gazapo Carretero, E; González Lahoz, JM; Martínez Blanco, ML; Verdejo Ortes, J, 1992) |
| " Because amphotericin B nephrotoxicity was suspected, further intravenous administration was stopped after a cumulative dosage of 2 g." | 1.28 | [Cryptococcal meningitis in AIDS: successful long-term prophylaxis with fluconazole]. ( Glück, T; Weber, P; Wiedmann, KH, 1991) |
| "Eight patients with AIDS were treated orally with 800 mg of fluconazole daily for cryptococcal meningitis for a mean duration of 4." | 1.28 | Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS. ( Berry, AJ; Graybill, JR; Rinaldi, MG, 1992) |
| "We conclude that most AIDS patients with dysphagia/odynophagia who do not respond to oral antifungals have an opportunistic infection of the esophagus." | 1.28 | Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment. ( Bianchi Porro, G; Cernuschi, M; Lazzarin, A; Parente, F; Rizzardini, G; Valsecchi, L, 1991) |
| "Treatment with amphotericin B, flucytosine and high doses of fluconazole was followed by clinical improvement, although CSF pleocytosis remained." | 1.28 | First report of chronic meningitis caused by Trichosporon beigelii. ( Boogaerts, M; Marcelis, L; Surmont, I; Verbist, L; Vergauwen, B; Verhoef, G, 1990) |
| "Fluconazole was superior to oral amphotericin B in the treatment of C." | 1.28 | Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis. ( Bordone, G; Colledan, M; Malaspina, C; Pagano, A; Paone, G; Rossi, G; Tortorano, AM; Viviani, MA, 1992) |
| "Fluconazole was 5-20-fold more active than ketoconazole against systemic aspergillosis and against systemic, intracranial and pulmonary cryptococcosis but was less active than amphotericin B." | 1.27 | Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. ( Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (1.69) | 18.7374 |
| 1990's | 76 (42.70) | 18.2507 |
| 2000's | 63 (35.39) | 29.6817 |
| 2010's | 29 (16.29) | 24.3611 |
| 2020's | 7 (3.93) | 2.80 |
| Authors | Studies |
|---|---|
| Guinea, J | 1 |
| Peláez, T | 2 |
| Recio, S | 1 |
| Torres-Narbona, M | 1 |
| Bouza, E | 2 |
| Miyazaki, T | 1 |
| Yamauchi, S | 1 |
| Inamine, T | 1 |
| Nagayoshi, Y | 1 |
| Saijo, T | 1 |
| Izumikawa, K | 1 |
| Seki, M | 1 |
| Kakeya, H | 1 |
| Yamamoto, Y | 1 |
| Yanagihara, K | 1 |
| Miyazaki, Y | 1 |
| Kohno, S | 1 |
| Liu, H | 1 |
| Shen, S | 1 |
| Wang, Q | 1 |
| Oki, Y | 1 |
| Nagano, S | 1 |
| Ishikawa, Y | 1 |
| Yamada, T | 1 |
| Ichimori, T | 1 |
| Uchida, K | 1 |
| Zhang, Y | 1 |
| Cooper, B | 1 |
| Gui, X | 1 |
| Sherer, R | 1 |
| Cao, Q | 1 |
| Rojas, AE | 1 |
| Pérez, JE | 1 |
| Hernández, JS | 1 |
| Zapata, Y | 1 |
| Jenks, JD | 1 |
| Cornely, OA | 2 |
| Chen, SC | 2 |
| Thompson, GR | 1 |
| Hoenigl, M | 1 |
| Bhagali, R | 1 |
| Prabhudesai, NP | 1 |
| Prabhudesai, MN | 1 |
| Wang, Y | 1 |
| Xing, Y | 1 |
| Chen, L | 2 |
| Meng, T | 1 |
| Li, Y | 2 |
| Xie, J | 1 |
| Dong, Y | 1 |
| Dong, W | 1 |
| Shokohi, T | 1 |
| Aslani, N | 1 |
| Ahangarkani, F | 1 |
| Meyabadi, MF | 1 |
| Hagen, F | 2 |
| Meis, JF | 1 |
| Boekhout, T | 2 |
| Kolecka, A | 1 |
| Badali, H | 1 |
| Muranda, AZ | 1 |
| Greeff, L | 1 |
| Sathekge, MM | 1 |
| Lengano, T | 1 |
| Karusseit, VOL | 1 |
| Guo, X | 1 |
| Zhang, R | 1 |
| Wang, Z | 1 |
| Ishchuk, OP | 1 |
| Ahmad, KM | 1 |
| Wee, J | 1 |
| Piskur, J | 1 |
| Shapiro, JA | 1 |
| Gu, Z | 1 |
| Khattab, A | 1 |
| Patruni, S | 1 |
| Sealey, ML | 1 |
| Choe, YJ | 1 |
| Blatt, DB | 1 |
| Yalcindag, A | 1 |
| Geffert, SF | 1 |
| Bobenchik, AM | 1 |
| Michelow, IC | 1 |
| Ding, YG | 1 |
| Fang, H | 1 |
| Wysham, NG | 1 |
| Sullivan, DR | 1 |
| Allada, G | 1 |
| Ziakas, PD | 1 |
| Kourbeti, IS | 1 |
| Mylonakis, E | 1 |
| Jørgensen, KJ | 2 |
| Gøtzsche, PC | 5 |
| Dalbøge, CS | 1 |
| Johansen, HK | 7 |
| Ricardo, E | 1 |
| Miranda, IM | 1 |
| Faria-Ramos, I | 1 |
| Silva, RM | 1 |
| Rodrigues, AG | 1 |
| Pina-Vaz, C | 1 |
| Takaoka, K | 1 |
| Nannya, Y | 1 |
| Shinohara, A | 1 |
| Arai, S | 1 |
| Nakamura, F | 1 |
| Kurokawa, M | 1 |
| Brissot, E | 1 |
| Cahu, X | 1 |
| Guillaume, T | 1 |
| Delaunay, J | 1 |
| Ayari, S | 1 |
| Peterlin, P | 1 |
| Le Bourgeois, A | 1 |
| Harousseau, JL | 1 |
| Milpied, N | 1 |
| Bene, MC | 1 |
| Moreau, P | 1 |
| Mohty, M | 1 |
| Chevallier, P | 1 |
| Wang, CH | 1 |
| Kan, LP | 1 |
| Lin, HA | 1 |
| Chang, FY | 1 |
| Wang, NC | 1 |
| Lin, TY | 1 |
| Chao, TY | 1 |
| Kao, WY | 1 |
| Ho, CL | 1 |
| Chen, YC | 1 |
| Dai, MS | 1 |
| Chang, PY | 1 |
| Wu, YY | 1 |
| Lin, JC | 1 |
| Sorrell, TC | 1 |
| Chang, CC | 1 |
| Paige, EK | 1 |
| Bryant, PA | 1 |
| Slavin, MA | 2 |
| Seneviratne, CJ | 1 |
| Fong, PH | 1 |
| Wong, SS | 1 |
| Lee, VH | 1 |
| Astvad, K | 1 |
| Høiby, N | 1 |
| Steptoe, P | 1 |
| Ishøy, T | 1 |
| Mohd Tap, R | 1 |
| Sabaratnam, P | 1 |
| Ramli, NY | 1 |
| Hashim, R | 1 |
| Mohd Fuat, AR | 1 |
| Ng, PP | 1 |
| Khairam, H | 1 |
| Ahmad, N | 1 |
| Desai, A | 2 |
| Fe, A | 1 |
| Ilowite, J | 1 |
| Cunha, BA | 1 |
| Mathew, JP | 1 |
| Chiriac, A | 1 |
| Mares, M | 1 |
| Mihaila, D | 1 |
| Solovan, C | 1 |
| Moldovan, C | 1 |
| Stolnicu, S | 1 |
| Kumar, S | 1 |
| Minz, M | 1 |
| Sinha, SK | 1 |
| Vaiphei, K | 1 |
| Sharma, A | 1 |
| Singh, S | 1 |
| Kenwar, DB | 1 |
| Muslimani, A | 1 |
| Francis, NS | 1 |
| Gopalakrishna, KV | 1 |
| Daw, HA | 1 |
| Shirley, RM | 1 |
| Baddley, JW | 1 |
| Celik, AD | 1 |
| Ozaras, R | 1 |
| Kantarcioglu, S | 1 |
| Mert, A | 1 |
| Tabak, F | 1 |
| Ozturk, R | 1 |
| Furman-Kuklińska, K | 1 |
| Naumnik, B | 1 |
| Myśliwiec, M | 1 |
| Plantinga, TS | 1 |
| van der Velden, WJ | 1 |
| Ferwerda, B | 1 |
| van Spriel, AB | 1 |
| Adema, G | 1 |
| Feuth, T | 1 |
| Donnelly, JP | 2 |
| Brown, GD | 1 |
| Kullberg, BJ | 1 |
| Blijlevens, NM | 1 |
| Netea, MG | 1 |
| Sancak, B | 1 |
| Alp, S | 1 |
| Hasçelik, G | 1 |
| Arikan, S | 1 |
| Cohen, Y | 1 |
| Karoubi, P | 1 |
| Adrie, C | 1 |
| Gauzit, R | 1 |
| Marsepoil, T | 1 |
| Zarka, D | 1 |
| Clec'h, C | 1 |
| Sawada, A | 1 |
| Sakata, N | 1 |
| Higuchi, B | 1 |
| Takeshita, Y | 1 |
| Ishihara, T | 1 |
| Sakata, A | 1 |
| Kouroki, M | 1 |
| Kondo, O | 1 |
| Koyama, M | 1 |
| Hirano, S | 1 |
| Yasui, M | 1 |
| Inoue, M | 1 |
| Yoshioka, A | 1 |
| Kawa, K | 1 |
| Sobel, JD | 1 |
| Luo, DQ | 1 |
| Chen, MC | 1 |
| Liu, JH | 1 |
| Li, Z | 1 |
| Li, HT | 1 |
| Inoue, Y | 1 |
| Onoda, M | 1 |
| Aihara, M | 1 |
| Koiwa, K | 1 |
| Yamane, Y | 1 |
| Ikezawa, Z | 1 |
| Aberg, J | 1 |
| Powderly, W | 1 |
| Tchernev, G | 1 |
| Penev, PK | 1 |
| Nenoff, P | 1 |
| Zisova, LG | 1 |
| Cardoso, JC | 1 |
| Taneva, T | 1 |
| Ginter-Hanselmayer, G | 1 |
| Ananiev, J | 1 |
| Gulubova, M | 1 |
| Hristova, R | 1 |
| Nocheva, D | 1 |
| Guarneri, C | 1 |
| Martino, G | 1 |
| Kanazawa, N | 1 |
| Mlinarić Missoni, E | 1 |
| Baršić, B | 1 |
| Goodman, D | 1 |
| Pamer, E | 1 |
| Jakubowski, A | 1 |
| Morris, C | 1 |
| Sepkowitz, K | 1 |
| Oliveira, JS | 1 |
| Kerbauy, FR | 1 |
| Colombo, AL | 1 |
| Bahia, DM | 1 |
| Pinheiro, GS | 1 |
| Silva, MR | 1 |
| Ribeiro, MS | 1 |
| Raineri, G | 1 |
| Kerbauy, J | 1 |
| Turgut, B | 1 |
| Vural, O | 1 |
| Demir, M | 1 |
| Kaldir, M | 1 |
| Singh, N | 1 |
| Muñoz, P | 1 |
| Fernández-Turégano, CP | 1 |
| Alcalá, L | 1 |
| Rodríguez-Créixems, M | 1 |
| Cheng, CL | 1 |
| Song, KP | 1 |
| Chee, SP | 1 |
| Chan, TK | 1 |
| Mattiuzzi, GN | 1 |
| Estey, E | 1 |
| Raad, I | 1 |
| Giles, F | 1 |
| Cortes, J | 1 |
| Shen, Y | 1 |
| Kontoyiannis, D | 1 |
| Koller, C | 1 |
| Munsell, M | 1 |
| Beran, M | 1 |
| Kantarjian, H | 1 |
| Yamaguchi, H | 1 |
| Baglivo, E | 1 |
| Seghelmeble, C | 1 |
| Bagnoud, M | 1 |
| Leuenberger, PM | 1 |
| Safran, AB | 1 |
| Winston, DJ | 3 |
| Maziarz, RT | 1 |
| Chandrasekar, PH | 2 |
| Lazarus, HM | 2 |
| Goldman, M | 1 |
| Blumer, JL | 1 |
| Leitz, GJ | 1 |
| Territo, MC | 1 |
| McGee, WT | 1 |
| Tereso, GJ | 1 |
| Silva, V | 1 |
| Zepeda, G | 1 |
| Alvareda, D | 1 |
| Heseltine, JC | 1 |
| Panciera, DL | 1 |
| Saunders, GK | 1 |
| Bagg, J | 1 |
| Sweeney, MP | 1 |
| Lewis, MA | 2 |
| Jackson, MS | 1 |
| Coleman, D | 1 |
| Al, MA | 1 |
| Baxter, W | 1 |
| McEndrick, S | 1 |
| McHugh, S | 1 |
| Redding, SW | 1 |
| Dahiya, MC | 1 |
| Kirkpatrick, WR | 1 |
| Coco, BJ | 1 |
| Patterson, TF | 2 |
| Fothergill, AW | 1 |
| Rinaldi, MG | 3 |
| Thomas, CR | 1 |
| Jung, S | 1 |
| Schelper, RL | 1 |
| Visvesvara, GS | 1 |
| Chang, HT | 1 |
| Lee, YA | 1 |
| Kim, HJ | 1 |
| Lee, TW | 1 |
| Kim, MJ | 1 |
| Lee, MH | 1 |
| Lee, JH | 1 |
| Ihm, CG | 1 |
| Wingard, JR | 2 |
| Stemmer, SM | 1 |
| Maor, Y | 1 |
| Hardan, I | 1 |
| Jantunen, E | 1 |
| Nihtinen, A | 1 |
| Volin, L | 1 |
| Juvonen, E | 1 |
| Parkkali, T | 1 |
| Ruutu, T | 1 |
| Anttila, VJ | 1 |
| Park, SB | 1 |
| Kang, MJ | 1 |
| Whang, EA | 1 |
| Han, SY | 1 |
| Kim, HC | 1 |
| Park, KK | 1 |
| Vardakas, KZ | 1 |
| Michalopoulos, A | 2 |
| Falagas, ME | 1 |
| Colombo, GL | 1 |
| Morlotti, L | 1 |
| Serra, G | 1 |
| Rerolle, JP | 1 |
| Szelag, JC | 1 |
| Diaconita, M | 1 |
| Paraf, F | 1 |
| Aldigier, JC | 1 |
| Le Meur, Y | 1 |
| Nomura, K | 1 |
| Kawasugi, K | 1 |
| Morimoto, T | 1 |
| Prentice, AG | 2 |
| Glasmacher, A | 1 |
| Djulbegovic, B | 1 |
| Benetatos, L | 1 |
| Hatzimichael, E | 1 |
| Vassou, A | 1 |
| Bourantas, KL | 1 |
| Tatetsu, H | 1 |
| Asou, N | 1 |
| Nakamura, M | 1 |
| Hanaoka, N | 1 |
| Matsuno, F | 1 |
| Horikawa, K | 1 |
| Mitsuya, H | 1 |
| Khyriem, AB | 1 |
| Sujatha, S | 1 |
| Parija, SC | 1 |
| Veroux, M | 1 |
| Corona, D | 1 |
| Macarone, M | 1 |
| Gagliano, M | 1 |
| Giuffida, G | 1 |
| Veroux, P | 1 |
| Ullmann, AJ | 2 |
| Lipton, JH | 1 |
| Vesole, DH | 1 |
| Chandrasekar, P | 1 |
| Langston, A | 1 |
| Tarantolo, SR | 1 |
| Greinix, H | 1 |
| Morais de Azevedo, W | 1 |
| Reddy, V | 1 |
| Boparai, N | 1 |
| Pedicone, L | 1 |
| Patino, H | 1 |
| Durrant, S | 2 |
| Maertens, J | 1 |
| Perfect, J | 1 |
| Walsh, TJ | 1 |
| Helfgott, D | 1 |
| Holowiecki, J | 1 |
| Stockelberg, D | 1 |
| Goh, YT | 1 |
| Petrini, M | 1 |
| Hardalo, C | 1 |
| Suresh, R | 1 |
| Angulo-Gonzalez, D | 1 |
| De Pauw, BE | 1 |
| Weiler, S | 1 |
| Bellmann, R | 1 |
| van Nieuwkoop, C | 1 |
| van Dissel, JT | 1 |
| Bonifaz, A | 1 |
| Macias, B | 1 |
| Paredes-Farrera, F | 1 |
| Arias, P | 1 |
| Ponce, RM | 1 |
| Araiza, J | 1 |
| Choi, JD | 1 |
| Powers, CJ | 1 |
| Vredenburgh, JJ | 1 |
| Friedman, AH | 1 |
| Sampson, JH | 1 |
| Kersun, LS | 1 |
| Reilly, AF | 1 |
| Ingram, ME | 1 |
| Nicholaou, MJ | 1 |
| McGowan, KL | 1 |
| Corvò, R | 1 |
| Amichetti, M | 1 |
| Ascarelli, A | 1 |
| Arcangeli, G | 1 |
| Buffoli, A | 1 |
| Cellini, N | 1 |
| Cionini, L | 1 |
| De Renzis, C | 1 |
| Emiliani, E | 1 |
| Franchini, P | 1 |
| Gabriele, P | 1 |
| Gobitti, C | 1 |
| Grillo Ruggieri, F | 1 |
| Bertoni, F | 1 |
| Magrini, SM | 1 |
| Marmiroli, L | 1 |
| Orsatti, M | 1 |
| Panizza, GM | 1 |
| Tordiglione, M | 1 |
| Ziccarelli, L | 1 |
| Gava, A | 1 |
| Zorat, PL | 1 |
| Ghelfi, R | 1 |
| Serra, GF | 1 |
| Vitale, V | 1 |
| Arning, M | 1 |
| Aul, C | 1 |
| Kunová, A | 1 |
| Trupl, J | 1 |
| Dluholucký, S | 1 |
| Galová, G | 1 |
| Krcméry, V | 1 |
| Meunier, F | 1 |
| Anaissie, EJ | 2 |
| Kontoyiannis, DP | 2 |
| Huls, C | 1 |
| Vartivarian, SE | 1 |
| Karl, C | 1 |
| Prince, RA | 1 |
| Bosso, J | 1 |
| Bodey, GP | 1 |
| McCann, J | 1 |
| Takabayashi, K | 1 |
| Nawata, Y | 1 |
| Sumida, T | 1 |
| Izumi, H | 1 |
| Otawa, M | 1 |
| Iwamoto, I | 1 |
| Tanabe, E | 1 |
| Tomioka, H | 1 |
| Sugiyama, T | 1 |
| Sueishi, M | 1 |
| Houston, S | 1 |
| Lipp, K | 1 |
| Cobian, L | 1 |
| Sinnott, JT | 1 |
| Osborne, B | 1 |
| Adams, R | 1 |
| Levenstein, MJ | 1 |
| Schoch, HG | 1 |
| Feldman, AR | 1 |
| Meyers, JD | 1 |
| Bowden, RA | 1 |
| Chubachi, A | 1 |
| Miura, I | 1 |
| Ohshima, A | 1 |
| Nishinari, T | 1 |
| Nimura, T | 1 |
| Niitsu, H | 1 |
| Miura, AB | 1 |
| Goodman, JL | 1 |
| Silber, JL | 1 |
| Horowitz, H | 1 |
| Shadduck, RK | 1 |
| Rosenfeld, CS | 1 |
| Ho, WG | 1 |
| Islam, MZ | 1 |
| Buell, DN | 1 |
| Akiba, Y | 1 |
| Osanai, S | 1 |
| Nakano, H | 1 |
| Matsumoto, H | 1 |
| Onodera, S | 1 |
| Sato, M | 1 |
| Saku, N | 1 |
| Takeda, A | 1 |
| Suzuki, N | 1 |
| Saito, T | 1 |
| Minato, N | 1 |
| Saito, K | 1 |
| Kano, S | 1 |
| Powles, RL | 1 |
| Mehta, J | 1 |
| Keiser, G | 1 |
| Schmid, M | 1 |
| Ishak, KG | 1 |
| Wirth, W | 1 |
| Vogt, M | 1 |
| Kauffman, CA | 2 |
| Ghannoum, MA | 1 |
| Gil, H | 1 |
| Aubin, F | 1 |
| Reboux, G | 1 |
| Barale, T | 1 |
| Humbert, P | 1 |
| Wakerly, L | 1 |
| Craig, AM | 1 |
| Malek, M | 1 |
| Hoffmeyer, U | 1 |
| Lloyd, A | 1 |
| Valette, F | 1 |
| Phillips, R | 1 |
| Zabihollah, M | 1 |
| Wahab, JA | 1 |
| Hanifah, MJ | 1 |
| Choo, KE | 1 |
| Kitamura, K | 1 |
| Miyagawa, K | 1 |
| Urabe, A | 1 |
| Sato, H | 1 |
| Obayashi, Y | 1 |
| Aoki, I | 1 |
| Takaku, F | 1 |
| Togawa, A | 1 |
| Shindou, E | 1 |
| Wakabayashi, Y | 1 |
| Ohshima, T | 1 |
| Horikoshi, A | 1 |
| Nomura, T | 1 |
| Ohki, I | 1 |
| Suzuki, K | 1 |
| Kamakura, M | 1 |
| Oguchi, A | 1 |
| Toyama, K | 1 |
| Yaguchi, M | 1 |
| Aoki, N | 1 |
| Kato, A | 1 |
| Mizoguchi, H | 1 |
| Masuda, M | 1 |
| Irie, S | 1 |
| Fujioka, S | 1 |
| Viscoli, C | 1 |
| Castagnola, E | 1 |
| Van Lint, MT | 1 |
| Moroni, C | 1 |
| Garaventa, A | 1 |
| Rossi, MR | 1 |
| Fanci, R | 1 |
| Menichetti, F | 1 |
| Caselli, D | 1 |
| Giacchino, M | 1 |
| Congiu, M | 1 |
| Kriaras, J | 1 |
| Geroulanos, S | 1 |
| Lai, PH | 1 |
| Lin, SM | 1 |
| Pan, HB | 1 |
| Yang, CF | 1 |
| Hedderwick, S | 1 |
| Odds, FC | 1 |
| Stratta, RJ | 1 |
| Presterl, E | 1 |
| Graninger, W | 1 |
| Tiao, GM | 1 |
| Martin, J | 1 |
| Weber, FL | 1 |
| Cohen, RM | 1 |
| Hanto, DW | 1 |
| Calvo, V | 1 |
| Borro, JM | 1 |
| Morales, P | 1 |
| Morcillo, A | 1 |
| Vicente, R | 1 |
| Tarrazona, V | 1 |
| París, F | 1 |
| Takatsuka, H | 1 |
| Takemoto, Y | 1 |
| Okamoto, T | 1 |
| Fujimori, Y | 1 |
| Tamura, S | 1 |
| Wada, H | 1 |
| Okada, M | 1 |
| Kanamaru, A | 1 |
| Kakishita, E | 1 |
| Colović, M | 1 |
| Lazarević, V | 1 |
| Colović, R | 1 |
| Janković, G | 1 |
| Suvajdzić, N | 1 |
| Bogdanović, A | 1 |
| Bila, J | 1 |
| Morgenstern, GR | 1 |
| Prentice, HG | 1 |
| Ropner, JE | 1 |
| Schey, SA | 1 |
| Warnock, DW | 1 |
| Huijgens, PC | 1 |
| Simoons-Smit, AM | 1 |
| van Loenen, AC | 1 |
| Prooy, E | 1 |
| van Tinteren, H | 1 |
| Ossenkoppele, GJ | 1 |
| Jonkhoff, AR | 1 |
| Gotzsche, PC | 1 |
| Young, GA | 1 |
| Bosly, A | 1 |
| Gibbs, DL | 1 |
| Cawley, MJ | 1 |
| Braxton, GR | 1 |
| Haith, LR | 1 |
| Reilly, KJ | 1 |
| Guilday, RE | 1 |
| Patton, ML | 1 |
| Wanic-Kossowska, M | 1 |
| Kozioł, L | 1 |
| Bajew, L | 1 |
| Roszkowiak, B | 1 |
| Czekalski, S | 1 |
| Furukawa, K | 1 |
| Sasaki, H | 1 |
| Pollard, RB | 1 |
| Suzuki, F | 1 |
| Trenschel, R | 1 |
| Peceny, R | 1 |
| Runde, V | 1 |
| Elmaagacli, A | 1 |
| Dermoumi, H | 1 |
| Heintschel von Heinegg, E | 1 |
| Müller, KD | 1 |
| Schaefer, UW | 1 |
| Beelen, DW | 1 |
| Gangadharan, VP | 1 |
| Sasidharan, K | 1 |
| Preetha, S | 1 |
| Chithrathara, K | 1 |
| Baran, J | 1 |
| Muckatira, B | 1 |
| Khatib, R | 1 |
| Gunsilius, E | 1 |
| Lass-Flörl, C | 1 |
| Kähler, CM | 1 |
| Gastl, G | 1 |
| Petzer, AL | 1 |
| Girmenia, C | 1 |
| Pagano, L | 1 |
| Leone, G | 1 |
| Martino, P | 1 |
| Marr, KA | 1 |
| Bauters, TG | 1 |
| Swinne, D | 1 |
| Noens, L | 1 |
| Nelis, HJ | 1 |
| Ellepola, AN | 1 |
| Samaranayake, LP | 1 |
| Nagasawa, M | 1 |
| Itoh, S | 1 |
| Tomizawa, D | 1 |
| Kajiwara, M | 1 |
| Sugimoto, T | 1 |
| Kumagai, J | 1 |
| Viviani, MA | 2 |
| Eloy, O | 1 |
| Joly, V | 1 |
| Ghnassia, JC | 1 |
| Carbon, C | 1 |
| Yeni, P | 1 |
| Hirasaki, S | 1 |
| Ijichi, T | 1 |
| Fujita, N | 1 |
| Araki, S | 1 |
| Gotoh, H | 1 |
| Nakagawa, M | 1 |
| Nightingale, SD | 1 |
| Cal, SX | 1 |
| Peterson, DM | 1 |
| Loss, SD | 1 |
| Gamble, BA | 1 |
| Watson, DA | 1 |
| Manzone, CP | 1 |
| Baker, JE | 1 |
| Jockusch, JD | 1 |
| Tortorano, AM | 1 |
| Malaspina, C | 1 |
| Colledan, M | 1 |
| Paone, G | 1 |
| Rossi, G | 1 |
| Bordone, G | 1 |
| Pagano, A | 1 |
| Bhabha, SK | 1 |
| Chowdhary, NK | 1 |
| Agarwal, A | 1 |
| Vivekanand, JH | 1 |
| Das, T | 1 |
| Sakhuja, V | 1 |
| Chugh, KS | 1 |
| Bren, A | 1 |
| Kandus, A | 1 |
| Lindic, J | 1 |
| Varl, J | 1 |
| Sugar, AM | 1 |
| Graybill, JR | 2 |
| Reynes, J | 1 |
| Mallié, M | 1 |
| André, D | 1 |
| Janbon, F | 1 |
| Bastide, JM | 1 |
| Laroche, R | 1 |
| Dupont, B | 1 |
| Touze, JE | 1 |
| Taelman, H | 1 |
| Bogaerts, J | 1 |
| Kadio, A | 1 |
| M'Pele, P | 1 |
| Latif, A | 1 |
| Aubry, P | 1 |
| Durbec, JP | 1 |
| Propst, T | 1 |
| Vogel, W | 1 |
| Propst, A | 1 |
| Dietze, O | 1 |
| Braunsteiner, H | 1 |
| Berry, AJ | 1 |
| Gazapo Carretero, E | 1 |
| García Aguado, C | 1 |
| Adrados de Llano, M | 1 |
| Martínez Blanco, ML | 1 |
| Verdejo Ortes, J | 1 |
| González Lahoz, JM | 1 |
| Samaranyake, LP | 1 |
| Lamey, PJ | 1 |
| Merz, WG | 1 |
| Johnson, TR | 1 |
| Karp, JE | 1 |
| Saral, R | 1 |
| Zalcman, G | 1 |
| Lechapt, E | 1 |
| Milleron, B | 1 |
| Denis, M | 1 |
| Mayaud, C | 1 |
| Akoun, G | 1 |
| Glück, T | 1 |
| Weber, P | 1 |
| Wiedmann, KH | 1 |
| Tschechne, B | 1 |
| Brunkhorst, U | 1 |
| Ruhnke, M | 1 |
| Trautmann, M | 1 |
| Dempe, S | 1 |
| Deicher, H | 1 |
| Mistlberger, A | 1 |
| Graf, B | 1 |
| Dupouy-Camet, J | 1 |
| Paugam, A | 1 |
| Di Donato, C | 1 |
| Viguié, C | 1 |
| Vicens, I | 1 |
| Volle, PJ | 1 |
| Tourte-Schaefer, C | 1 |
| Bergami, G | 1 |
| Di Mario, M | 1 |
| Barbuti, D | 1 |
| Cozza, R | 1 |
| Vincent-Ballereau, FN | 1 |
| Patey, ON | 1 |
| Lafaix, C | 1 |
| Blancard, A | 1 |
| Moulin-Traffort, J | 1 |
| Regli, P | 1 |
| Sarzier, JM | 1 |
| Quilici, M | 1 |
| Gil, A | 1 |
| Lavilla, P | 1 |
| Valencia, E | 1 |
| Pintado, V | 1 |
| Dupla, ML | 1 |
| Khamashta, MA | 1 |
| García-Puig, J | 1 |
| Ortiz-Vázquez, J | 1 |
| Parente, F | 1 |
| Cernuschi, M | 1 |
| Rizzardini, G | 1 |
| Lazzarin, A | 1 |
| Valsecchi, L | 1 |
| Bianchi Porro, G | 1 |
| Gill, SK | 1 |
| Poizot-Martin, I | 1 |
| Grob, JJ | 1 |
| Fournerie, JR | 1 |
| Dhiver, C | 1 |
| Andrac, L | 1 |
| Gastaut, JA | 1 |
| Bonerandi, JJ | 1 |
| Heise, W | 1 |
| Arasteh, K | 1 |
| L'age, M | 1 |
| Schweigart, U | 1 |
| Allescher, HD | 1 |
| Lucey, DR | 1 |
| Lucey, CR | 1 |
| Larsen, RA | 2 |
| Leal, MA | 1 |
| Chan, LS | 1 |
| Ganzinger, U | 1 |
| Freeman, EM | 1 |
| Surmont, I | 1 |
| Vergauwen, B | 1 |
| Marcelis, L | 1 |
| Verbist, L | 1 |
| Verhoef, G | 1 |
| Boogaerts, M | 1 |
| Moncino, MD | 1 |
| Gutman, LT | 1 |
| Dietrich, D | 1 |
| Keil, TU | 1 |
| Troke, PF | 1 |
| Andrews, RJ | 1 |
| Marriott, MS | 1 |
| Richardson, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Studies of Disorders With Increased Susceptibility to Fungal Infections[NCT01222741] | 850 participants (Anticipated) | Observational | 2011-01-07 | Recruiting | |||
| Long-term Versus Short-term Sequential Therapy (Intravenous Itraconazole Followed by Oral Solution) of Itraconazole as Primary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation[NCT01160952] | Phase 2 | 120 participants (Anticipated) | Interventional | 2009-05-31 | Recruiting | ||
| AMBINEB: Clinical Trial to Evaluate Tolerance and Safety of Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis in Patients With Acute Myeloid Leukemia and Allogeneic Haematopoietic Progenitor Cell Transplant (A[NCT00391014] | Phase 2 | 150 participants (Anticipated) | Interventional | 2006-01-31 | Completed | ||
| Evaluation of Antifungal Prophylaxis Against Invasive Fungal Infections During Corticosteroid Containing Therapy for Graft-versus-host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation[NCT01282879] | Phase 4 | 36 participants (Actual) | Interventional | 2009-12-31 | Terminated (stopped due to In interim analysis, this study met the primary hypothesis.) | ||
| A Randomized Trial of Tamoxifen Combined With Amphotericin B and Fluconazole for Cryptococcal Meningitis[NCT03112031] | Phase 2 | 50 participants (Actual) | Interventional | 2017-10-10 | Completed | ||
| [NCT00034645] | Phase 3 | 600 participants (Actual) | Interventional | 1999-01-31 | Completed | ||
| Invasive Fungal Infections in Patients Following Stem Cell Transplant[NCT04619147] | 300 participants (Anticipated) | Observational | 2021-01-31 | Not yet recruiting | |||
| A Randomized Controlled Trial of Posaconazole (SCH 56592) vs. Standard Azole Therapy for the Prevention of Invasive Fungal Infections Among High-Risk Neutropenic Patients[NCT00044486] | Phase 3 | 602 participants (Actual) | Interventional | 2002-07-31 | Completed | ||
| Revision of Antifungal Strategies Definitions for Invasive Fungal Infections (Proven/Probable/Possible) in Patients With Hematological Malignancies (REDEFI-SEIFEM)[NCT04024995] | 513 participants (Actual) | Observational [Patient Registry] | 2019-09-01 | Completed | |||
| Pharmacokinetics of a Fluconazole Loading Dose in Infants and Toddlers[NCT00797420] | Phase 1 | 13 participants (Actual) | Interventional | 2008-11-30 | Completed | ||
| ANTIVORIFUNGOL:Strategy of Antifungal Use in Oncohematological Neutropenic Patients. Use of Voriconazole as Early Treatment.[NCT00386802] | Phase 4 | 115 participants (Anticipated) | Interventional | 2006-08-31 | Completed | ||
| A Phase III, Randomized, Double-Blind, Comparative Trial of FK463 Versus Fluconazole for Prophylaxis of Fungal Infections in Patients Undergoing a Hematopoetic Stem Cell Transplant[NCT00001937] | Phase 3 | 800 participants | Interventional | 1999-11-30 | Completed | ||
| A Pilot Study to Determine the Safety and Clinical Efficacy of Once-Weekly Inhaled AmBisome for the Prevention of Aspergillus Colonization in Lung Transplant Recipients[NCT01254708] | Phase 2 | 4 participants (Anticipated) | Interventional | 2012-01-31 | Suspended (stopped due to Study has been placed on hold due to unavailability of funding.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
43 reviews available for fluconazole and Opportunistic Infections
| Article | Year |
|---|---|
Clinical diversity of invasive cryptococcosis in AIDS patients from central China: report of two cases with review of literature.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amphotericin B; Antifungal Agents; Antigen | 2019 |
Breakthrough invasive fungal infections: Who is at risk?
Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillus; Candida; Central Venous Catheters; Echinoca | 2020 |
Cryptococcus albidus Fungemia in an Immunosuppressed Child: Case Report and Systematic Literature Review.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Child, Preschool; Cry | 2020 |
Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Echinocandins; Fluconazole; Hematopoietic Stem Cell Trans | 2014 |
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms | 2014 |
Nystatin prophylaxis and treatment in severely immunodepressed patients.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Fluconazole; Humans; Immunoc | 2014 |
Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Invasive; Child; Child, Preschool; Consensus; Cri | 2014 |
Subcutaneous Infection Associated with Trichosporon ovoides: A Case Report and Review of Literature.
Topics: Antifungal Agents; Dermatomycoses; DNA, Intergenic; Female; Fluconazole; Humans; Immunocompromised H | 2016 |
Cryptococcal lung disease.
Topics: Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Immunocompromised Host; Lung Diseases, Funga | 2009 |
Spondylodiscitis due to an emergent fungal pathogen: Blastoschizomyces capitatus, a case report and review of the literature.
Topics: Aged; Amphotericin B; Antifungal Agents; Dipodascus; Discitis; Fluconazole; Humans; Itraconazole; Ke | 2009 |
Disseminated Penicillium marneffei infection in an SLE patient: a case report and literature review.
Topics: Amphotericin B; Antifungal Agents; China; Dermatomycoses; Female; Fluconazole; Humans; Itraconazole; | 2011 |
HIV: primary and secondary prophylaxis for opportunistic infections.
Topics: AIDS-Related Opportunistic Infections; Fluconazole; HIV Infections; Humans; Isoniazid; Opportunistic | 2010 |
Onychomycosis: modern diagnostic and treatment approaches.
Topics: Antifungal Agents; Candidiasis; Combined Modality Therapy; Dermatomycoses; DNA, Fungal; Enzyme-Linke | 2013 |
The changing face of invasive aspergillosis in liver transplant recipients.
Topics: Antifungal Agents; Aspergillosis; Fluconazole; Humans; Kidney; Liver; Liver Transplantation; Opportu | 2002 |
Nystatin prophylaxis and treatment in severely immunodepressed patients.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Fluconazole; Humans; Immunocompromised Ho | 2002 |
[Antifungal drug].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Design; Drug Res | 2003 |
Balamuthia mandrillaris meningoencephalitis in an immunocompetent patient: an unusual clinical course and a favorable outcome.
Topics: Aged; Animals; Brain Neoplasms; Central Nervous System Protozoal Infections; Clarithromycin; Diagnos | 2004 |
First report of Cryptococcus albidus--induced disseminated cryptococcosis in a renal transplant recipient.
Topics: Adult; Antifungal Agents; Cryptococcosis; Cyclosporine; Diagnosis, Differential; Fluconazole; Graft | 2004 |
Empirical antifungal therapy in treating febrile neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Deoxycholic Acid; Drug Combinations; Fe | 2004 |
Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials.
Topics: Antifungal Agents; Chi-Square Distribution; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem C | 2005 |
Voriconazole versus amphotericin B in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms | 2006 |
In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy.
Topics: Antifungal Agents; Fluconazole; Hematologic Neoplasms; Humans; Itraconazole; Mycoses; Opportunistic | 2006 |
[Prophylaxis against mycoses in neutropenic patients].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Fluconaz | 1994 |
[Therapy of systemic candidiasis].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Burns; Candidiasis; Flucon | 1994 |
[A case report--pulmonary cryptococcosis associated with systemic lupus erythematosus and review of 44 cases in Japan].
Topics: Arthritis, Rheumatoid; Cryptococcosis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; | 1993 |
Systemic fungal infections: major problems in cancer patients.
Topics: Antifungal Agents; Antineoplastic Agents; Bone Marrow Transplantation; Fluconazole; Humans; Immunoco | 1994 |
Role of azoles in antifungal therapy.
Topics: Antifungal Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Fluconazole; Humans; Itraco | 1996 |
Is antifungal susceptibility testing useful in guiding fluconazole therapy?
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Fluconazole; Fungi; Humans; I | 1996 |
Opportunistic fungal infections: filamentous fungi and cryptococcosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Cryptococcosis; Fluconazole; Humans; Middle | 1997 |
[Changes in epidemiology of opportunistic infections due to Candida].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Blood; Bone Marrow Transplantation; Candid | 1995 |
[New aspects in treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Humans; Mycoses; Opportun | 1998 |
Trichosporon beigelii infection: experience in a regional burn center.
Topics: Adult; Amphotericin B; Antifungal Agents; Burns; Catheters, Indwelling; Drug Resistance, Microbial; | 2000 |
Antifungal prophylaxis in hematopoietic stem cell transplant recipients.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; | 2001 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agen | 2000 |
Nystatin prophylaxis and treatment in severely immunodepressed patients.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Fluconazole; Humans; Immunocompromised Ho | 2002 |
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Th | 1992 |
Fluconazole.
Topics: Animals; Fluconazole; Humans; Mycoses; Opportunistic Infections | 1992 |
Diagnosis and treatment of oral candidosis.
Topics: Antifungal Agents; Candidiasis, Oral; Chronic Disease; Fluconazole; HIV Infections; Humans; Immune T | 1991 |
[Pleuropulmonary cryptococcosis disclosing AIDS].
Topics: Acquired Immunodeficiency Syndrome; CD4-Positive T-Lymphocytes; Cryptococcosis; Fluconazole; Humans; | 1991 |
Fluconazole. Review and situation among antifungal drugs in the treatment of opportunistic mycoses of human immuno-deficiency virus infections.
Topics: Acquired Immunodeficiency Syndrome; Fluconazole; Humans; Mycoses; Opportunistic Infections | 1991 |
[Mollusca contagiosa-like cutaneous cryptococcosis in AIDS: a case].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Dermatomycoses; Diagnosis | 1991 |
Azoles and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ke | 1990 |
[New, registered specialty drugs in Austria. Diflucan, Fungata].
Topics: Animals; Candidiasis; Fluconazole; Humans; Mycoses; Opportunistic Infections | 1990 |
23 trials available for fluconazole and Opportunistic Infections
| Article | Year |
|---|---|
[Comparison of micafungin and fosfluconazole as prophylaxis for invasive fungal infection during neutropenia in children undergoing chemotherapy and hematopoietic stem cell transplantation].
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Fluconazole; | 2009 |
Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Drug Thera | 2003 |
Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Female; Fluconazole; Hematopoietic Stem | 2003 |
Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Female; Fluconazole; Hematopoietic Stem | 2003 |
Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Female; Fluconazole; Hematopoietic Stem | 2003 |
Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Female; Fluconazole; Hematopoietic Stem | 2003 |
Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Female; Fluconazole; Hematopoietic Stem | 2003 |
Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Female; Fluconazole; Hematopoietic Stem | 2003 |
Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Female; Fluconazole; Hematopoietic Stem | 2003 |
Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Female; Fluconazole; Hematopoietic Stem | 2003 |
Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Female; Fluconazole; Hematopoietic Stem | 2003 |
Oral fluconazole for empiric treatment of prolonged Fever in neutropenic patients: prospective study in 250 consecutive patients after stem cell transplantation.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemo | 2004 |
Caspofungin in kidney transplant recipients with refractory invasive candidiasis.
Topics: Antifungal Agents; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Esophagus; Fluc | 2007 |
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Female; Fluconazole; | 2007 |
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Female; Fluconazole; | 2007 |
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Female; Fluconazole; | 2007 |
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Female; Fluconazole; | 2007 |
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Flucon | 2007 |
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Flucon | 2007 |
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Flucon | 2007 |
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Flucon | 2007 |
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Flucon | 2007 |
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Flucon | 2007 |
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Flucon | 2007 |
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Flucon | 2007 |
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Flucon | 2007 |
Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis, Oral; Double-Blind Metho | 2008 |
Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections.
Topics: Adolescent; Adult; Aged; Aspergillus; Dose-Response Relationship, Drug; Female; Fluconazole; Fusariu | 1995 |
[Effects of fluconazole on onychomycosis in the patients with collagen diseases].
Topics: Adult; Collagen Diseases; Female; Fluconazole; Humans; Male; Middle Aged; Onychomycosis; Opportunist | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind M | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind M | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind M | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind M | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind M | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind M | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind M | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind M | 1995 |
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Double-Blind M | 1995 |
Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Fluconazole; | 1993 |
[Clinical study on a concomitant therapy with fluconazole and human recombinant granulocyte colony stimulating factor in the treatment of systemic fungal infections with hematological disorders].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Drug Therapy, Combination; Female; Filgrastim; Fl | 1996 |
Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amphotericin B; Antifungal Agents; Child; Child, Preschool | 1996 |
Fluconazole versus amphotericin B for the prevention of fungal infection in neutropenic patients with hematologic malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Female; Fluconazole; | 1999 |
A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents, Phytogenic; Drug Interactions; Fe | 1999 |
Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.
Topics: Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Fluconazole; Hematologic Neoplasms; Hem | 1999 |
A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia. Antifungal Prophylaxis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; | 1999 |
Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; | 2000 |
Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Cryptococcosis; Double-Blind Met | 1992 |
[Fluconazole in therapy of candidiasis of the oropharyngeal space in patients with HIV infection. Results of an open multicenter study of assessing the effectiveness and tolerance of fluconazole].
Topics: Administration, Oral; Adult; Aged; Candidiasis, Oral; Female; Fluconazole; HIV Infections; Humans; I | 1991 |
Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Esophagitis; Female; Fluconazole; Humans; Ma | 1991 |
Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; | 1990 |
112 other studies available for fluconazole and Opportunistic Infections
| Article | Year |
|---|---|
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.
Topics: Antifungal Agents; Aspergillus; Candida; Fluconazole; Fungi; Fusarium; Humans; Microbial Sensitivity | 2008 |
Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata.
Topics: Animals; Antifungal Agents; Base Sequence; Calcineurin; Candida glabrata; Candidiasis; DNA Primers; | 2010 |
Recurrent pulmonary cryptococcosis during chronic HBV infection: A case report.
Topics: Antifungal Agents; Cryptococcosis; Cryptococcus; Fluconazole; Hepatitis B virus; Hepatitis B, Chroni | 2021 |
Ulcerative colitis successfully treated with vedolizumab in the presence of comorbid opportunistic infections: a case report.
Topics: Colitis, Ulcerative; Cytomegalovirus Infections; Fluconazole; Humans; Inflammatory Bowel Diseases; M | 2023 |
Quantitative analysis of the expression of fluconazole-resistant genes in strains of Candida albicans isolated from elderly people at their admission in an intensive care unit in Manizales, Colombia
Topics: Aged; Candida albicans; Candidiasis; Carrier Proteins; Colombia; Colony Count, Microbial; Cross Infe | 2020 |
Post COVID-19 opportunistic candida retinitis: A case report.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; COVID-19; Eye Infections, Fungal; Fluco | 2021 |
Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Cost-Benefit Analysis; Female; Fluconazole; | 2018 |
Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients.
Topics: Adolescent; Antifungal Agents; Candida; Candidiasis; Caspofungin; Child, Preschool; Echinocandins; F | 2018 |
Cryptococcoma of a transplanted kidney in a patient presenting with recurrent urinary tract infection: a case report.
Topics: Adult; Antifungal Agents; Bacterial Infections; Biopsy; Coinfection; Cryptococcosis; Cryptococcus ne | 2018 |
Understand the genomic diversity and evolution of fungal pathogen Candida glabrata by genome-wide analysis of genetic variations.
Topics: Candida glabrata; Candidiasis; DNA Copy Number Variations; Drug Resistance, Fungal; Evolution, Molec | 2020 |
Rare presentation of cryptococcal meningitis in an immunocompetent patient.
Topics: Agricultural Workers' Diseases; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Diplopia | 2019 |
Edematous erythema, subcutaneous plaques, and severe pain in the lower extremities in an immunocompromised patient.
Topics: Antifungal Agents; Biopsy; Cryptococcosis; Cryptococcus neoformans; Edema; Erythema; Female; Flucona | 2013 |
An opportunistic infection associated with ruxolitinib, a novel janus kinase 1,2 inhibitor.
Topics: Aged; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Enzyme Inhibitors; Fluconazole; Hu | 2013 |
In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei.
Topics: Adult; Antifungal Agents; Antineoplastic Agents; ATP-Binding Cassette Transporters; Candida; Candidi | 2014 |
A novel scoring system to predict the incidence of invasive fungal disease in salvage chemotherapies for malignant lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; C | 2014 |
Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation.
Topics: Acute Disease; Adult; Aged; Chemoprevention; Female; Fluconazole; Humans; Leukemia; Male; Middle Age | 2015 |
Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Antifungal Agents; Child; Female; Fluconazole; Hematopoie | 2016 |
Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Carcinoma; Caspofungin; Chemoradiotherapy; Chemotherapy | 2015 |
Oropharyngeal Candidiasis in Palliative Care Patients in Denmark.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis, Oral; Denmark; Drug Resista | 2015 |
A Case of Pneumonia Caused by Pneumocystis Jirovecii and Cryptococcus Neoformans in a Patient with HTLV-1 Associated Adult T- Cell Leukemia/Lymphoma: Occam's Razor Blunted.
Topics: Adrenal Cortex Hormones; Anti-Infective Agents; Antifungal Agents; Cryptococcosis; Cryptococcus neof | 2016 |
Primary cutaneous cryptococcosis during infliximab therapy.
Topics: Administration, Oral; Aged; Antifungal Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; | 2017 |
Esophageal tuberculosis with coexisting opportunistic infections in a renal allograft transplant recipient.
Topics: Antifungal Agents; Antitubercular Agents; Antiviral Agents; Candidiasis, Oral; Deglutition Disorders | 2017 |
Disseminated cryptococcosis in a patient with idiopathic CD4+ T-lymphocytopenia.
Topics: Adult; CD4 Lymphocyte Count; Cryptococcosis; Female; Fluconazole; Humans; Immunocompromised Host; Ly | 2008 |
Fungaemia due to Cryptococcus laurentii as a complication of immunosuppressive therapy--a case report.
Topics: Adult; Antifungal Agents; Cryptococcosis; Cryptococcus; Fluconazole; Fungemia; Glomerulonephritis, M | 2009 |
Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Hematopoietic | 2009 |
[Investigation of in vitro activities of fluconazole, itraconazole and voriconazole against clinical isolates of Blastoschizomyces capitatus (Geotrichum capitatum) by two different methods].
Topics: Antifungal Agents; Dipodascus; Fluconazole; Geotrichosis; Humans; Itraconazole; Microbial Sensitivit | 2009 |
Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.
Topics: Adult; Aged; Antifungal Agents; Candida glabrata; Candidiasis; Cohort Studies; Critical Care; Critic | 2010 |
Changing trends in the epidemiology of Candida blood stream infections: a matter for concern?
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Critical Care; Cross-Sectional Studies; Drug Resis | 2010 |
Cryptococcal cellulitis in a patient with myelodysplastic syndrome.
Topics: Aged, 80 and over; Antifungal Agents; Cellulitis; Cryptococcosis; Cryptococcus neoformans; Debrideme | 2011 |
Two rare cases of central nervous system opportunistic mycoses.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus nidulans; Cryptococcus neoformans; Female; Flu | 2012 |
Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Bone Marrow Transpla | 2002 |
Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Femal | 2002 |
Candida arthritis in a patient with chronic myelogenous leukemia (CML) in blastic transformation, unresponsive to fluconazole, but treated effectively with liposomal amphotericin B.
Topics: Amphotericin B; Arthritis, Infectious; Blast Crisis; Candidiasis; Drug Combinations; Drug Resistance | 2002 |
Frequency and clinical significance of bloodstream infections caused by C albicans strains with reduced susceptibility to fluconazole.
Topics: Antifungal Agents; Candidiasis; Drug Resistance, Microbial; Female; Fluconazole; Follow-Up Studies; | 2002 |
PCR-aided diagnosis of fungal chorioretinitis following ingestion of traditional Chinese medication.
Topics: Aged; Amphotericin B; Antifungal Agents; Chorioretinitis; DNA, Fungal; Drug Therapy, Combination; Dr | 2002 |
Indocyanine green angiographic features in endogenous Candida chorioretinis.
Topics: Adult; Antifungal Agents; Candidiasis; Chorioretinitis; Female; Fluconazole; Fluorescein Angiography | 2003 |
Summaries for patients. Preventing fungal infections in patients with stem-cell transplants.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Female; Fluconazole; Hematopoietic Stem | 2003 |
Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; | 2003 |
[Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
Topics: Amphotericin B; Antifungal Agents; Chile; Communicable Diseases, Emerging; Cross Infection; Drug Res | 2003 |
Systemic candidiasis in a dog.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Catheters, Indwelling; Dog Diseases; Dogs | 2003 |
High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Resistance, Fungal; Female; Fluconazole; Hum | 2003 |
Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer.
Topics: Adult; Aged; Antifungal Agents; Candida glabrata; Candidiasis, Oral; Carcinoma, Squamous Cell; Chemo | 2004 |
Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Female; Fluconazole; Fungemia; Graft vs Hos | 2004 |
A case of primary cutaneous aspergillosis in a renal transplant recipient.
Topics: Antifungal Agents; Aspergillosis; Fluconazole; Humans; Immunocompromised Host; Kidney Failure, Chron | 2004 |
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromise | 2005 |
Intracranial granuloma and skull osteolysis: complication of a primary cutaneous cryptococcosis in a kidney transplant recipient.
Topics: Abscess; Amphotericin B; Animals; Antifungal Agents; Combined Modality Therapy; Cryptococcosis; Debr | 2005 |
Cost-effectiveness analysis of antifungal treatment for patients on chemotherapy.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Cohort Studies; Cost-Benefit Analys | 2006 |
Cryptococcus lung infection complicating fludarabine treatment in a chronic lymphocytic leukemia patient.
Topics: Aged; Antifungal Agents; Antineoplastic Agents; Cryptococcosis; Fluconazole; Humans; Leukemia, Lymph | 2007 |
Torsades de pointes upon fluconazole administration in a patient with acute myeloblastic leukemia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Fluconazole; Humans; Leuk | 2006 |
Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Hu | 2006 |
Prophylaxis and aspergillosis--has the principle been proven?
Topics: Antifungal Agents; Aspergillosis; Fluconazole; Graft vs Host Disease; Humans; Itraconazole; Mycoses; | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Ac | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodyspla | 2007 |
Palatal zygomycosis: experience of 21 cases.
Topics: Absidia; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain Diseases; Child; Diabetic | 2008 |
Cryptococcal meningitis in patients with glioma: a report of two cases.
Topics: Adult; Aged; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Agents, Alk | 2008 |
Antifungal susceptibility against yeasts isolated from pediatric oncology patients.
Topics: Adolescent; Adult; Antifungal Agents; Candida; Candidiasis; Catheterization, Central Venous; Child; | 2008 |
Use of fluconazole is not associated with a higher incidence of Candida krusei and other non-albicans Candida species.
Topics: Antifungal Agents; Bacteremia; Bronchoalveolar Lavage Fluid; Candida; Candidiasis; Fluconazole; Huma | 1995 |
Deadly fungal infections spreading in cancer patients.
Topics: Antineoplastic Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Mycoses; Neoplasms; Opportun | 1995 |
Skin rash in a renal transplant recipient.
Topics: Administration, Oral; Cryptococcosis; Dermatomycoses; Female; Fluconazole; Humans; Kidney Transplant | 1995 |
Risk factors for hepatosplenic abscesses in patients with acute leukemia receiving empiric azole treatment.
Topics: Abscess; Acute Disease; Adolescent; Adult; Aged; Candidiasis; Female; Fever; Fluconazole; Humans; Le | 1994 |
Successful antifungal treatment of disseminated candidiasis associated with ARDS.
Topics: Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Middle Aged; Oppor | 1993 |
[Candidiasis of the liver following successful chemotherapy of acute myeloid leukemia (Fab type 6) and recovery with oral fluconazole therapy].
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candidiasis; Female; Flucon | 1996 |
[Cutaneous and lymphatic cryptococcosis after transient lymphopenia in an immunocompetent patient].
Topics: Aged; Aged, 80 and over; Cryptococcosis; Female; Fluconazole; Groin; Humans; Immunocompetence; Leg D | 1995 |
Fluconazole versus oral polyenes in the prophylaxis of immunocompromised patients: a cost-minimization analysis.
Topics: Antifungal Agents; Antineoplastic Agents; Bone Marrow Transplantation; Costs and Cost Analysis; Deci | 1996 |
Bruton's agammaglobulinaemia in a child presenting with cryptococcal empyema thoracis and periauricular pyogenic abscess.
Topics: Abscess; Agammaglobulinemia; Amphotericin B; Ceftazidime; Child, Preschool; Cloxacillin; Combined Mo | 1995 |
Systemic candidiasis in cardiac surgery patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Critical Care; Cross Inf | 1997 |
Disseminated miliary cerebral candidiasis.
Topics: Amphotericin B; Antifungal Agents; Brain; Candidiasis; Child, Preschool; Combined Modality Therapy; | 1997 |
Ganciclovir/acyclovir and fluconazole prophylaxis after simultaneous kidney-pancreas transplantation.
Topics: Acyclovir; Administration, Oral; Antifungal Agents; Antiviral Agents; Fluconazole; Ganciclovir; Huma | 1998 |
Addisonian crisis in a liver transplant patient due to fluconazole withdrawal.
Topics: Addison Disease; Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Female; Fluconazole; Humans; | 1999 |
Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Immunosuppressive | 1999 |
Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Immunosuppressive | 1999 |
Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Immunosuppressive | 1999 |
Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Immunosuppressive | 1999 |
Hepatosplenic candidiasis after neutropenic phase of acute leukaemia.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candidiasi | 1999 |
Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Meta-Analysis as Topic; Mycoses; Neoplasms; | 1999 |
[Factors causing renal failure in patients with disseminated lupus erythematosus: description of three cases].
Topics: Adult; Antifungal Agents; Antiviral Agents; Candidiasis; Female; Fluconazole; Ganciclovir; Herpes Zo | 1999 |
Lanoconazole, a new imidazole antimycotic compound, protects MAIDS mice against encephalitis caused by Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Brain; Cryptococcosis; Cryptococcus neoformans; Cytokines; Encephalitis; | 2000 |
Chronic systemic (hepatosplenic) candidiasis in a patient with granulocytic sarcoma.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candidiasi | 2000 |
Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Drug Util | 2001 |
Candida ciferrii, a new fluconazole-resistant yeast causing systemic mycosis in immunocompromised patients.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fatal Outcome; Fluconazole; Hum | 2001 |
Fluconazole and Candida krusei fungemia.
Topics: Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Italy; Opportunistic Infections | 2001 |
Why prior fluconazole use is associated with an increased risk of invasive mold infections in immunosuppressed hosts: an alternative hypothesis.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Microbial; Fluconazole; H | 2002 |
Repeated isolation of Cryptococcus laurentii from the oropharynx of an immunocompromized patient.
Topics: Antifungal Agents; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fatal Outcome; Fluconazole | 2002 |
Invasive subglottal aspergillosis in a patient with severe aplastic anemia: a case report.
Topics: Adult; Amphotericin B; Anemia, Aplastic; Anti-Inflammatory Agents; Antifungal Agents; Aspergillosis; | 2002 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole | 1992 |
Fungemia caused by Hansenula anomala: successful treatment with fluconazole.
Topics: Carcinoma, Small Cell; Female; Fluconazole; Fungemia; Humans; Lung Neoplasms; Middle Aged; Opportuni | 1992 |
Primary prophylaxis with fluconazole against systemic fungal infections in HIV-positive patients.
Topics: Adult; CD4-Positive T-Lymphocytes; Female; Fluconazole; Follow-Up Studies; HIV Infections; Humans; L | 1992 |
Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis.
Topics: Adolescent; Adult; Amphotericin B; Aspergillosis; Candidiasis; Child; Child, Preschool; Fluconazole; | 1992 |
Nervous system cryptococcosis in the immunocompromised.
Topics: AIDS-Related Opportunistic Infections; Cryptococcus neoformans; Developing Countries; Fluconazole; H | 1992 |
Efficacy of oral fluconazole in Cryptococcus neoformans infection.
Topics: Administration, Oral; Adult; Cryptococcus neoformans; Fluconazole; Humans; Kidney Transplantation; M | 1992 |
Fluconazole in the treatment of fungal infections in kidney-transplanted patients.
Topics: Candidiasis; Fluconazole; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; | 1992 |
[Treatment and secondary prophylaxis with fluconazole for oropharyngeal candidiasis in HIV-positive patients. A mycological analysis of failures].
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Candida albicans; Candidiasis, Oral; Female; | 1992 |
Cryptococcal meningitis associated with acquired immunodeficiency syndrome (AIDS) in African patients: treatment with fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Drug Evaluation; Female; Fluconazole; Humans; Male; Meningitis, | 1992 |
Successful treatment of recurrent hepatic Candida infection with fluconazole after chemotherapy for acute leukemia: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Candidiasis; Fluconazole; Fungemia; H | 1992 |
Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Fluconazole; Humans; Male; Meningit | 1992 |
[Cryptococcosis in AIDS patients: a study of 19 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; | 1992 |
Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.
Topics: Adult; Amphotericin B; Bone Marrow Transplantation; Candidiasis; Drug Therapy, Combination; Fluconaz | 1991 |
[Cryptococcal meningitis in AIDS: successful long-term prophylaxis with fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antigens, Bacterial; Cryptococcus; Drug T | 1991 |
[Endogenous candida endophthalmitis: a new therapy].
Topics: Adult; Candidiasis; Colitis, Ulcerative; Colonic Polyps; Drug Administration Schedule; Endophthalmit | 1991 |
[Resistance to fluconazole in hospitalized patients. Concordance between Candida albicans resistance in vitro and therapeutic failure].
Topics: Acquired Immunodeficiency Syndrome; Candida albicans; Candidiasis; Dose-Response Relationship, Drug; | 1991 |
[The echographic diagnosis of Candida albicans cystitis in childhood].
Topics: Candidiasis; Child; Cystitis; Dysgerminoma; Female; Fluconazole; Humans; Opportunistic Infections; S | 1991 |
[Laboratory's controls of antifungal treatment by the fluconazole of the candidiasis in immunocompromised patients].
Topics: Acquired Immunodeficiency Syndrome; Candida albicans; Candidiasis; Dose-Response Relationship, Drug; | 1991 |
Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Administration, Oral; Adult; Amphotericin B; Antifung | 1991 |
Clinical aspects of HIV and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Fluconazole; Ganciclovir; HIV Infections; Humans; Opportunistic | 1990 |
[Diflucan therapy--exchange of clinical experience based on case reports of opportunistic mycoses. Bad Neuenahr, 18 August 1990].
Topics: Fluconazole; Humans; Mycoses; Opportunistic Infections | 1990 |
[The therapy of Candida esophagitis in AIDS patients with fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Esophagitis; Esophagoscopy; Fluconazole; Humans; Op | 1990 |
[Systemic candidiasis in intensive care patients after antibiotic therapy].
Topics: Anti-Bacterial Agents; Candidiasis; Fluconazole; Humans; Intensive Care Units; Opportunistic Infecti | 1990 |
Infectious disease emergencies in persons with HIV/AIDS: an update.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Clindamycin; Communicable Diseases; Fluconazole; | 1990 |
AIDS file. New oral antifungal may replace i.v. treatment.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Candidiasis, Oral; Fluconazole; Humans; Op | 1990 |
First report of chronic meningitis caused by Trichosporon beigelii.
Topics: Adolescent; Amphotericin B; Chronic Disease; Drug Therapy, Combination; Fluconazole; Flucytosine; Hu | 1990 |
Fluconazole approved for AIDS complications.
Topics: Acquired Immunodeficiency Syndrome; Fluconazole; Humans; Opportunistic Infections | 1990 |
Severe systemic cryptococcal disease in a child: review of prognostic indicators predicting treatment failure and an approach to maintenance therapy with oral fluconazole.
Topics: Administration, Oral; Amphotericin B; Child; Cryptococcosis; Female; Fluconazole; Humans; Opportunis | 1990 |
[AIDS: bad prognosis in candidiasis. Cryptococcosis in brain involvement is usually fatal--experiences with a new therapeutic drug].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Meningit | 1989 |
[AIDS fungus infections. Fluconazole--a new preparation in development].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Fluconazol | 1989 |
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus | 1987 |